Positions are currently available to measure epigenetic changes that occur in intestinal development and disease, and during the oncogenic progression of colorectal cancer. The projects will employ mouse models, organoid cultures, and epigenomic (ChIP-seq) methodologies. Postdocs are encouraged to take any developed projects with them as their careers progress.
We have a small (5 lab members) but vibrant laboratory with non-overlapping but complementary interests in intestinal development and disease. Our lab benefits from being situated at the heart of Rutgers’ primary science campus. Rutgers presents a vibrant research community, with $137.1M in NIH funding and $397.2M in total research funding (FY2013). Rutgers sits 43 miles from New York City and 66 miles from Philadelphia and enjoys an exciting and diverse academic community in central New Jersey.
1. Ph.D in Molecular Biology or related field.
2. The candidate must have published first-author papers in prestigious journals.
3. Experience in next-generation sequencing analysis and/or R is desirable but not required.
A collaborative spirit and a strong interest in science are required.
We'd love to have you join us. Please send your CV to Mike Verzi if interested!